2014
DOI: 10.1016/j.bone.2014.01.009
|View full text |Cite
|
Sign up to set email alerts
|

Bone cell-independent benefits of raloxifene on the skeleton: A novel mechanism for improving bone material properties

Abstract: Raloxifene is an FDA approved agent used to treat bone loss and decrease fracture risk. In clinical trials and animal studies, raloxifene reduces fracture risk and improves bone mechanical properties, but the mechanisms of action remain unclear because these benefits occur largely independent of changes to bone mass. Using a novel experimental approach, machined bone beams, both from mature male canine and human male donors, were depleted of living cells and then exposed to raloxifene ex vivo. Our data show th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
84
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 85 publications
(93 citation statements)
references
References 37 publications
7
84
2
Order By: Relevance
“…All animals were on protocols that were approved by the Institutional Animal Care and Use Committee prior to their use. Femora from skeletally mature (15-24 mo/old) treatment naïve male hounds were machined into prismatic beams (N = 8-12 beams per experimental group) following the details described previously [15]. Beams were subjected to at least one freeze-thaw cycle to ensure eradication of cellular activity.…”
Section: Mechanical Testingmentioning
confidence: 99%
See 3 more Smart Citations
“…All animals were on protocols that were approved by the Institutional Animal Care and Use Committee prior to their use. Femora from skeletally mature (15-24 mo/old) treatment naïve male hounds were machined into prismatic beams (N = 8-12 beams per experimental group) following the details described previously [15]. Beams were subjected to at least one freeze-thaw cycle to ensure eradication of cellular activity.…”
Section: Mechanical Testingmentioning
confidence: 99%
“…Beams were subjected to at least one freeze-thaw cycle to ensure eradication of cellular activity. Absence of any cellular activity after a single freeze-thaw was demonstrated by lactate dehydrogenase immunostaining of fresh and frozen-thawed bone and the results have been published in [15]. Specified compounds were dissolved in dimethyl sulfoxide (DMSO) and then added to incubation media (1X PBS with 1% penicillin-streptomycin supplementation) at a 2 μM concentration.…”
Section: Mechanical Testingmentioning
confidence: 99%
See 2 more Smart Citations
“…Although both requirements have been alleviated with the advent of environmental SEM, which can image samples 'wet' and under moderate pressures and has thus enabled in situ experiments of biological samples, reported in situ SEM experiments have been very limited until now for bone tissue, because they currently cannot provide sufficient spatial resolution that would allow assessment of the bone ultrastructure organization. X-ray-based techniques such as SAXS and WAXS have been used in recent years for in situ experiments [149,150,152,[276][277][278][279]. However, these studies have been carried out for a limited number of discrete points in space within the sample only, and they could not provide quantitative results in terms of the 3D orientation of the ultrastructure.…”
Section: Combination With In Situ Mechanical Testingmentioning
confidence: 99%